Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

NCT02623998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: insulin glargine
DRUG: sitagliptin/metformin
BEHAVIORAL: lifestyle therapy

Sponsor

Population Health Research Institute

Collaborators

[object Object]